CNS Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
157.4M
+3.1%
152.7M
+4.9%
145.6M
+1.3%
143.8M
+1.5%
141.7M
Cost of Revenue
0
0
0
0
0
Gross Profit
157.4M
+3.1%
152.7M
+4.9%
145.6M
+1.3%
143.8M
+1.5%
141.7M
Operating Expenses
106.4M
+6.4%
100.0M
+4.6%
95.5M
-36.6%
150.7M
+62.4%
92.8M
R&D
0
0
0
0
0
SG&A
81.6M
+1.5%
80.5M
+5.0%
76.6M
+1.8%
75.3M
+1.8%
74.0M
Operating Income
51.1M
-3.2%
52.8M
+5.3%
50.1M
+824.9%
-6914000
-114.1%
48.9M
EBITDA
54.2M
-3.0%
55.9M
+5.0%
53.3M
+1481.0%
-3856000
-107.4%
51.9M
Net Income
40.8M
-26.5%
55.6M
+34.8%
41.2M
+34.3%
30.7M
-26.3%
41.6M
EPS (Basic)
$0.82
-14.6%
$0.96
+17.1%
$0.82
+20.6%
$0.68
-16.0%
$0.81
EPS (Diluted)
$0.81
-14.7%
$0.95
+15.9%
$0.82
+20.6%
$0.68
-16.0%
$0.81
Shares (Diluted)
52.1M
+0.5%
51.9M
+0.5%
51.6M
-0.1%
51.6M
+0.1%
51.6M
Cohen & Steers (CNS) — Financials